Figure 1.
OS by treatment arm. aStratified by age (18 to <75, ≥75 years) and cytogenetic risk (intermediate, poor). Aza, azacitidine; CI, confidence interval; HR, hazard ratio; NR, not reached; OS, overall survival; Pbo, placebo; Ven, venetoclax.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.